Cardiovascular risk factor management in patients with RA compared to matched non-RA patients

Rheumatology (United Kingdom)

Volumn 55, Issue 5, 2016, Pages 809-816

  Alemao, Evo ^a   Cawston, Helene ^b   Bourhis, Francois ^b   Al, Maiwenn ^c   Rutten van Mölken, Maureen P M H ^c   Liao, Katherine P ^d   Solomon, Daniel H ^d  

^a BRISTOL MYERS SQUIBB   (United States)

^b MAPI   (France)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiovascular; Cohort; Diabetes; Dyslipidaemia; Goal; Hypertension; Management; Prescription; RA

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; LIPID; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; UNITED KINGDOM; ADOLESCENT; AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMPLICATION; DISEASE MANAGEMENT; DRUG UTILIZATION; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; DRUG UTILIZATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED KINGDOM; YOUNG ADULT;

EID: 84965034307     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev427     Document Type: Article

References (28)

1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis:a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7.
2. Kaplan MJ. Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am 2010;36:405-26.
3. Meune C, Touzé E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2009;48:1309-13.
4. Goodson N, Symmons D. Rheumatoid arthritis in women:still associated with an increased mortality. Ann Rheum Dis 2002;61:955-6.
5. Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E. Total mortality is increased in rheumatoid arthriti. A 17-year prospective study. Clin Rheumatol 2001;20:123-7.
6. Solomon DH, Goodson NJ, Katz JN et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608-12.
7. del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
8. Aubry MC, Maradit-Kremers H, Reinalda MS et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007;34:937-42.
9. Aviña-Zubieta JA, Abrahamowicz M, De Vera MA et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology 2013;52:68-75.
10. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population- based cohort study. Arthritis Rheum 2008;58:2268-74.
11. Naranjo A, Sokka T, Descalzo MA et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008;10:R30.
12. Barnabe C, Martin BJ, Ghali WA. Systematic review and meta-analysis: anti-tumor necrosis factor a therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res 2011;63:522-9.
13. Westlake SL, Colebatch AN, Baird J et al. Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2011;50:518-31.
14. Bartels CM, Kind AJ, Everett C et al. Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritis. Arthritis Rheum 2011;63:1221-30.
15. Toms TE, Panoulas VF, Kitas GD. Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J 2011;5:64-75.
16. Souto A, Salgado E, Maneiro JR et al. Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol 2015;67:117-27.
17. Thomas SL, Edwards CJ, Smeeth L, Cooper C, Hall AJ. How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum 2008;59:1314-21.
18. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
19. Liao KP, Solomon DH. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology 2013;52:45-52.
20. Chung CP, Giles JT, Petri M et al. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012;41:535-44.
21. Choi HK, Seeger JD. Lipid profiles among US elderly with untreated rheumatoid arthritis-the Third National Health and Nutrition Examination Survey. J Rheumatol 2005;32:2311-6.
22. Gabriel SE, Crowson CS. Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2012;24:171-6.
23. Liao KP, Cai T, Gainer VS et al. Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population. Arthritis Care Res 2013;65:2046-50.
24. Bartels CM, Johnson H, Voelker K et al. Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care. Arthritis Care Res 2014;66:1281-8.
25. Bartels CM, Kind AJ, Thorpe CT et al. Lipid testing in patients with rheumatoid arthritis and key cardiovascularrelated comorbidities: a medicare analysis. Semin Arthritis Rheum 2012;42:9-16.
26. MacLean CH, Louie R, Leake B et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92.
27. Peters MJ, Symmons DP, McCarey D et al. EULAR evidence- based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-31.
28. Heslinga M et al. Is cardiovascular risk management in patients with rheumatoid arthritis effective? Two year follow up reveals unexpected rise in cardiovascular risk! Ann Rheum Dis 2015;74(Suppl 2):192.